Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
22
Named actors
14
Disclosed $ (bull / bear)
size unknown / $350K + 2 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-16 | Chief Accounting Officer Abate Kristin | sold | $2K | SEC ↗ |
| 2026-10-08 | 5%+ holder (13G) — reduced stake ACORN BIOVENTURES, L.P. | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-10-01 | Chief Accounting Officer Abate Kristin | sold | $450 | SEC ↗ |
| 2026-09-25 | 5%+ holder (13G) — reduced stake ACORN BIOVENTURES, L.P. | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-09-01 | Chief Accounting Officer Abate Kristin | sold | $38 | SEC ↗ |
4 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-28 | 5%+ holder (13G) BlackRock, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) Ikarian Capital, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) ACORN BIOVENTURES, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-14 | EVP, CLO&Secretary Mano Michael | sold | $3K | SEC ↗ |
| 2026-05-14 | President and CEO Paulson Richard A. | sold | $21K | SEC ↗ |
| 2026-05-14 | Chief Accounting Officer Abate Kristin | sold | $504 | SEC ↗ |
| 2026-05-14 | EVP & Chief Commercial Officer Cheng Sohanya Roshan | sold | $3K | SEC ↗ |
| 2026-05-14 | EVP & Chief Medical Officer Rangwala Reshma | sold | $4K | SEC ↗ |
| 2026-05-14 | EVP, Chief Development Officer Poulton Stuart | sold | $4K | SEC ↗ |
| 2026-05-13 | 5%+ holder (13G) Adage Capital Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-12 | 5%+ holder (13G) GOLDMAN SACHS GROUP INC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-21 | EVP & Chief Medical Officer Rangwala Reshma | sold | $4K | SEC ↗ |
| 2026-04-02 | 5%+ holder (13G) RA CAPITAL MANAGEMENT, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-02 | 5%+ holder (13G) Commodore Capital LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-02 | President and CEO Paulson Richard A. | sold | $116K | SEC ↗ |
| 2026-03-02 | EVP & Chief Medical Officer Rangwala Reshma | sold | $48K | SEC ↗ |
| 2026-03-02 | EVP, CLO&Secretary Mano Michael | sold | $33K | SEC ↗ |
| 2026-03-02 | EVP & Chief Commercial Officer Cheng Sohanya Roshan | sold | $43K | SEC ↗ |
| 2026-03-02 | EVP, Chief Development Officer Poulton Stuart | sold | $48K | SEC ↗ |
| 2026-03-02 | Chief Accounting Officer Abate Kristin | sold | $5K | SEC ↗ |